Homocamptothecin, an E-ring-modified camptothecin, exerts more potent antiproliferative activity than other topoisomerase I inhibitors in human colon cancers obtained from surgery and maintained in vitro under histotypical culture conditions. [electronic resource]
- Clinical cancer research : an official journal of the American Association for Cancer Research Apr 2000
- 1557-62 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1078-0432
Antineoplastic Agents--pharmacology Biopsy Camptothecin--analogs & derivatives Cell Division--drug effects Colon--drug effects Colonic Neoplasms--drug therapy Culture Techniques DNA Topoisomerases, Type I--metabolism Dose-Response Relationship, Drug Doxorubicin--pharmacology Enzyme Inhibitors--pharmacology Etoposide--pharmacology Humans Irinotecan Thymidine--metabolism Topoisomerase I Inhibitors Topotecan--pharmacology Tritium Tumor Cells, Cultured